Related Experiment Video
Updated: May 25, 2026

Non-Viral Engineering of Primary Human T Cells via Homology-Mediated End-Joining Targeted Integration of Large DNA Templates
Published on: May 9, 2025
[Toward gene and cell therapy using human artificial chromosome].
Yasuhiro Kazuki1, Mitsuo Oshimura
1Department of Biomedical Science, Institute of Regenerative Medicine and Biofunction, Graduate School of Medical Science, Tottori University.
Human artificial chromosomes (HACs) offer stable gene delivery for physiological regulation. Combining HACs with patient-specific stem cells shows promise for treating genetic diseases like Duchenne muscular dystrophy.
Area of Science:
- Genetics and Genomics
- Cell Biology
- Biotechnology
Context:
- Human artificial chromosomes (HACs) are investigated as advanced gene delivery vectors.
- Patient-specific stem cells (e.g., iPS cells) offer immune compatibility for therapies.
- Duchenne muscular dystrophy is a severe genetic disorder requiring effective treatment strategies.
Purpose:
- To evaluate the potential of HAC technology for gene delivery and genetic correction.
- To explore the use of patient-derived stem cells for personalized gene and cell therapies.
- To demonstrate the feasibility of correcting genetic deficiencies using HACs in patient-derived cells.
Summary:
- HACs provide stable episomal maintenance and can carry large genomic loci for physiological gene regulation.
- A study successfully corrected a genetic defect in induced pluripotent stem cells (iPS cells) from a Duchenne muscular dystrophy patient using HAC technology.
- This approach combines the advantages of HACs with the immune benefits of autologous stem cells.
Impact:
- The combination of patient-specific stem cells and HACs represents a potent strategy for gene and cell therapies.
- This technology holds significant potential for treating genetic disorders by enabling precise gene correction.
- Successful application in Duchenne muscular dystrophy could pave the way for treating other genetic diseases.
More Related Videos
09:29Clinical Application of Sleeping Beauty and Artificial Antigen Presenting Cells to Genetically Modify T Cells from Peripheral and Umbilical Cord Blood
Published on: February 1, 2013
12:04Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells
Published on: March 10, 2023
Related Concept Videos
Gene Therapy
Gene Therapy
Methods of Nuclear Reprogramming